Tag: FDA Advisory Committee

FDA Advisory Committee

Regulatory/FDA

Follow-up on Accelerated Drug Approvals Is Subject of FDA Advisory Panel

Follow-up on Accelerated Drug Approvals Is Subject of FDA Advisory Panel

May 6, 2021 – The outcome of a recent Advisory Committee meeting convened to review the uses of certain cancer drugs that were approved under the Food and Drug Administration’s (FDA’s) accelerated approval process sheds light on the potential pitfalls of the process after the approvals are granted. The FDA Oncologic Drugs Advisory Committee voted […]

Read more